Monday, September 11, 2017
AngioDynamics Announces Secondary Offering of 2,250,000 Shares of Common Stock by Selling Stockholders
ALBANY, N.Y. , Aug. 01, 2016 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that Avista Capital Partners, LP and affiliated investment...

  Monday, September 11, 2017
AngioDynamics Issues Statement Regarding Stryker recall of Angiographic Catheters
AngioDynamics Issues Statement Regarding Stryker recall of Angiographic Catheters   ALBANY, N.Y., July 27, 2016 -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, issued...

  Monday, September 11, 2017
AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer
Greiner brings more than 20 years of accounting, corporate finance and operations experience from a variety of global corporations...

  Monday, September 11, 2017
AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results
Q4 Net sales of $93.4 million , up 3% year-over-year Q4 GAAP loss per share of $1.21 , inclusive of a one-time tax asset write down of $40.1 million ; Non-GAAP adjusted EPS of $0.19 , up 37% year-over-year Q4 Operating cash generation of $18.5 million FY2017 revenue guidance set at $355-$360...

  Monday, September 11, 2017
AngioDynamics to Report Fiscal 2016 Fourth Quarter and Full Year Financial Results
ALBANY, N.Y. , June 29, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 fourth...

  Monday, September 11, 2017
AngioDynamics Reports Fiscal 2016 Third Quarter Results
Net sales of $87.4 million , up 1% year-over-year GAAP earnings per share of $0.02 ; Non-GAAP adjusted EPS of $0.15 , up 25% year-over-year Operating cash generation of $12.4 million FY2016 financial guidance updated   ALBANY, N.Y. , April 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a...

  Monday, September 11, 2017
AngioDynamics Appoints James C. Clemmer as New President and Chief Executive Officer
Clemmer brings more than 25 years of operational, manufacturing, marketing and business development experience in the global healthcare industry...

  Monday, September 11, 2017
AngioDynamics to Report Fiscal 2016 Third Quarter Financial Results
ALBANY, N.Y. , March 29, 2016 (GLOBE NEWSWIRE) -- AngioDynamics  (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 third...

  Monday, September 11, 2017
AngioDynamics and Merz North America Establish Multi-Year Relationship to Market Asclera for Vein Patients
ALBANY, N.Y. , March 10, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that they have signed an agreement with Merz North America ,...

  Monday, September 11, 2017
AngioDynamics to Present at the Barclays Global Healthcare Conference
ALBANY, N.Y. , March 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer,...

  Monday, September 11, 2017
AngioDynamics Announces the Approval of the Celerity PICC Tip Confirmation System With Navigation in Canada
ALBANY, N.Y. , Feb. 08, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Celerity PICC Tip Confirmation System with Navigation has...

  Monday, September 11, 2017
AngioDynamics Reports Fiscal 2016 Second Quarter Results
Net sales of $89.2 million GAAP loss of $0.01 per share; Non-GAAP adjusted EPS of $0.14 Operating cash generation of $9.6 million ALBANY, N.Y. , Jan. 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access,...

  Monday, September 11, 2017
AngioDynamics to Present at the 34th Annual J.P. Morgan Global Healthcare Conference
ALBANY, N.Y. , Jan. 04, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph DeVivo , President and Chief Executive Officer, is...

  Monday, September 11, 2017
AngioDynamics to Report Fiscal 2016 Second Quarter Financial Results
ALBANY, N.Y. , Dec. 28, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 second...

  Monday, September 11, 2017
FDA Lifts Warning Letters on AngioDynamics' Facilities
Completes Resolution of All Outstanding Warning Letters...